EIDOS A Mechanistic Classification of Adverse Drug Effects

被引:20
作者
Ferner, Robin E. [1 ,2 ]
Aronson, Jeffrey K. [3 ]
机构
[1] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England
[2] Univ Birmingham, Dept Clin Pharmacol, Birmingham, W Midlands, England
[3] Dept Primary Hlth Care, Oxford, England
关键词
RECEPTORS; FLUID; DOTS; TIME;
D O I
10.2165/11318910-000000000-00000
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The mechanisms of adverse drug effects have not been adequately classified. Here, we propose a comprehensive mechanistic classification or adverse drug effects that considers five elements: the Extrinsic chemical species (E) that initiates the effect; the Intrinsic chemical species (1) that it affects; the Distribution (D) of these species in the body; the (physiological or pathological) Outcome (O); and the Sequela (S), which is the adverse effect. This classification, which we have called EIDOS, describes the mechanism by which an adverse effect Occurs; it complements the DoTS classification of adverse effects (based oil clinical pharmacology), which takes into account Dose responsiveness, Time course, and Susceptibility factors. Together, these two classification systems, mechanistic and clinical, comprehensively delineate all the important aspects of adverse drug reactions; they should contribute to areas such as drug development and regulation, pharmacovigilance, monitoring therapy, and the prevention, diagnosis, and treatment of adverse drug effects.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 49 条
[21]   HYPERNATREMIA DURING LITHIUM AND TICARCILLIN THERAPY [J].
FINCH, RA .
SOUTHERN MEDICAL JOURNAL, 1981, 74 (03) :376-377
[22]   Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [J].
Gelderblom, H ;
Verweij, J ;
Nooter, K ;
Sparreboom, A .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) :1590-1598
[23]   Milk-alkali syndrome with metastatic calcification [J].
Goldsmith, DJA .
AMERICAN JOURNAL OF MEDICINE, 1996, 100 (04) :481-482
[25]   Acetaminophen-induced hepatotoxicity [J].
James, LP ;
Mayeux, PR ;
Hinson, JA .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (12) :1499-1506
[26]   NON-SEDATING ANTIHISTAMINES [J].
KALINER, MA ;
CHECK, WA .
ALLERGY PROCEEDINGS, 1988, 9 (06) :649-663
[27]   Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide [J].
Knight, A ;
Askling, J ;
Granath, F ;
Sparen, P ;
Ekbom, A .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1307-1311
[28]  
LoVecchio F, 2003, WILD ENVIRON MED, V14, P220, DOI 10.1580/1080-6032(2003)14[220:SSFAOA]2.0.CO
[29]  
2